ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

Solomon Gard’s Questions/Answers

January 2, 1981

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

ACS Updates Guidelines On Colorectal Screening.

February 2, 2001